Conference Theme: Translating Health Research into Policy and Practice for Health of the PopulationPoster Presentations - Emerging / Infectious Diseases: no. P65-Ab0010INTRODUCTION: Neuraminidase (NA) inhibitors are one of the limited options for the control of influenza. The H275Y NA mutation, which confers resistance to oseltamivir carboxylate, was initially considered to be of little clinical consequence due to limited detection of this mutation in field isolates prior to 2007-2008, when a globally spreading H275Y variant emerged. Oseltamivir-resistant A(H1N1)pdm09 viruses with the H275Y NA mutation has been reported since 2009 but have not replaced the …published_or_final_versio
Highly pathogenic avian H5N1 influenza viruses remain a pandemic threat. Antiviral drugs such as neu...
Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing r...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Conference Theme: Translating Health Research into Policy and Practice for Health of the PopulationP...
Limited antiviral compounds are available for the control of influenza, and the emergence of resista...
Neuraminidase (NA) inhibitors are one of two classes of antiviral compounds available for the contro...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
textabstractOnly two classes of antiviral drugs, neuraminidase inhibitors and adamantanes, are appro...
The His^(274)→Tyr^(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidas...
© 2019 Rubaiyea FarrukeeInfluenza viruses can cause severe respiratory disease and are responsible f...
The 2009 pandemic H1N1 (H1N1pdm09) influenza virus is naturally susceptible to neuraminidase (NA) in...
The acquisition of neuraminidase (NA) inhibitor resistance by H5N1 influenza viruses has serious cli...
Highly pathogenic avian H5N1 influenza viruses remain a pandemic threat. Antiviral drugs such as neu...
Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing r...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Conference Theme: Translating Health Research into Policy and Practice for Health of the PopulationP...
Limited antiviral compounds are available for the control of influenza, and the emergence of resista...
Neuraminidase (NA) inhibitors are one of two classes of antiviral compounds available for the contro...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
textabstractOnly two classes of antiviral drugs, neuraminidase inhibitors and adamantanes, are appro...
The His^(274)→Tyr^(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidas...
© 2019 Rubaiyea FarrukeeInfluenza viruses can cause severe respiratory disease and are responsible f...
The 2009 pandemic H1N1 (H1N1pdm09) influenza virus is naturally susceptible to neuraminidase (NA) in...
The acquisition of neuraminidase (NA) inhibitor resistance by H5N1 influenza viruses has serious cli...
Highly pathogenic avian H5N1 influenza viruses remain a pandemic threat. Antiviral drugs such as neu...
Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing r...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...